Abstract
1-Hydroxy-2-(2-pyridyl)ethanedisphosphonic acid monosodium salt (HPEDP) was prepared and labeled with 99mTc using two different reducing agents: SnCl2·2H2O and NaBH4; NaBH4 gave better results. The radiochemical purity of 99mTc(NaBH4)-HPEDP was 96 ± 4%, and the complex was stable in vitro for 6 h. The in vivo biodistribution studies performed in mice show highly selective uptake of the labeled compound in the skeletal system and rapid elimination via the urinary pathway. The maximum bone uptake was 32.3 ± 2.1% ID/organ.
Similar content being viewed by others
References
Kruger, S., Buck, A.K., Mottaghy, F.M., et al., Eur. J. Nucl. Med. Mol. Imag., 2009, vol. 36, pp. 1807–1812.
Lavender, J.P., Khan, R.A., and Hughes, S.P., J. Nucl. Med., 1979, vol. 20, pp. 413–418.
Budd, R.S., Hodgson, G.S., and Hare, W.S., Br. J. Radiol., 1989, vol. 62, pp. 314–317.
Budd, R.S., Hodgson, G.S., and Hare, W.S., Br. J. Radiol., 1989, vol. 62, pp. 318–320.
Galasko, C.S., Clin. Nucl. Med., 1980, vol. 5, pp. 565–568.
Fellner, M., Biesalski, B., Bausbacher, N., et al., Nucl. Med. Biol., 2012, vol. 39, pp. 993–999.
Wang, D., Miller, S.C., Shlyakhtenko, L.S., et al., Bioconjug. Chem., 2007, vol. 18, pp. 1375–1378.
Ogawa, K. and Saji, H., Int. J. Mol. Imag., 2011, vol. 2011, paper 537 687.
Mari, C. and Catafau, A., Q. J. Nucl. Med., 1999, vol. 43, pp. 259–267.
Meyer, J.L. and Nancollas, G.H., Calcif. Tissue Res., 1973, vol. 13, pp. 295–303.
Kruger, S., Buck, A.K., Mottaghy, F.M., et al., Eur. J. Nucl. Med. Mol. Imag., 2009, vol. 36, pp. 1807–1812.
Tanabe, S., Zodda, J.P., Deutsch, E., and Heineman, W.R., Int. J. Appl. Radiat. Isot., 1983, vol. 34, pp. 1577–1584.
Demirkan, B., Baskan, Z., Alacacioglu, A., et al., Tumori, 2005, vol. 91, pp. 77–80.
Subramanian, G., McAfee, J.G., Blair, R.J., et al., J. Nucl. Med., 1975, vol. 16, pp. 744–755.
Notni, J., Pohle, K., and Wester, H.J., EJNMMI Res., 2012, vol. 2, p. 28.
Domstad, P.A., Coupal, J.J., Kim, E.E., et al., Radiology, 1980, vol. 136, pp. 209–211.
Love, C., Din, A.S., Tomas, M.B., et al., Radiographics, 2003, vol. 23, pp. 341–358.
Sanad, M.H., Synthesis and labeling of some organic compounds with technetium-99m, MSc Thesis, Cairo (Egypt): Zagazig Univ. (Banha Branch), Faculty of Science, 2004.
Sanad, M.H., Tallat, H.M., and Ahmed, S.M.F., Radiochim. Acta, 2017, doi: org/10.1515/ract-2017-2840.
Sanad, M.H. and Borai, E.H., Radiochim. Acta, 2015, vol. 103, no. 12, pp. 879–891.
Sanad, M.H., Borai, E.H., and Fouzy, A.S.M., J. Environ. Sci., Toxicol. Food Technol., 2014, vol. 8, no. 12, p. 10.
Sanad, M.H. and El-Tawoosy, M., J. Radioanal. Nucl. Chem., 2013, vol. 298, pp. 1105–1109.
Sanad, M.H. and Ibrahim, I.T., Radiochemistry, 2013, vol. 55, no. 3, pp. 341–345.
Sanad, M.H., Radiochemistry, 2013, vol. 55, no. 5, pp. 539–544.
Sanad, M.H., J. Anal. Sci. Technol., 2014, vol. 5, no. 1, p. 23.
Sanad, M.H., Ibrahim, A.A., and Talaat, H.M., J. Radioanal. Nucl. Chem., 2018, vol. 315, pp. 57–63.
Sanad, M.H., Synthesis and labeling of some organic compounds with one of the most radioactive isotopes, PhD Thesis, Cairo (Egypt): Ain Shams Univ., Faculty of Science, 2007.
De Rosales, R.T.M., Finucane, C., Mather, S.J., and Blower, P.J., Chem. Commun., 2009, pp. 4847–4849.
Ogawa, K., Mukai, T., Arano, Y., et al., Bioconjug. Chem., 2005, vol. 16, pp. 751–757.
Ogawa, K., Mukai, T., Asano, D., et al., J. Nucl. Med., 2007, vol. 48, pp. 122–127.
Srinivasa Rao, D.V.N., Dandala, R., Lenin, R., et al., ARKIVOC, 2007, vol. XIV, pp. 34–38.
Gracheva, M.A., Ilyushchenko, O.N., Kodina, G.E., and Levin, V.I., J. Label. Compd. Radiopharm., 1982, vol. 19, nos. 11–12, p. 1535.
Owunwanne, A., Marinsky, J., and Blau, M., J. Nucl. Med., 1977, vol. 18, no. 11, p. 1099.
Jain, V., Swarnakar, N.K., Mishra, P.R., et al., Biomaterials, 2012, vol. 33, no. 29, p. 7206.
Banerjee, T., Singh, A.K., Sharma, R.K., and Maitra, A.N., Int. J. Pharm., 2005, vol. 289, nos. 1–2, p. 189.
Subramanian, G. and McAfee, J.G., J. Nucl. Med., 1969, vol. 10, p. 443.
Ogawa, K., Mukai, T., Arano, Y., et al., J. Label. Compd. Radiopharm., 2004, vol. 47, pp. 753–761.
Ogawa, K., Mukai, T., Arano, Y., et al., Nucl. Med. Biol., 2006, vol. 33, pp. 513–520.
Libson, K., Deutsch, E., and Barnett, B.L., J. Am. Chem. Soc., 1980, vol. 102, pp. 2476–2478.
Ogawa, K., Mukai, T., Inoue, Y., et al., J. Nucl. Med., 2006, vol. 47, pp. 2042–2047.
Verbeke, K., Rozenski, J., Cleynhens, B., et al., Bioconjug. Chem., 2002, vol. 13, pp. 16–22.
Kasugai, S., Fujisawa, R., Waki, Y., et al., J. Bone Miner. Res., 2000, vol. 15, pp. 936–943.
Yokogawa, K., Miya, K., Sekido, T., et al., Endocrinology, 2001, vol. 142, pp. 1228–1233.
Yoneda, T., Sasaki, A., and Mundy, G.R., Breast Cancer Res. Treat., 1994, vol. 32, pp. 73–84.
Palma, E., Oliveira, B.L., Correia, J.D., et al., J. Bioinorg. Chem., 2007, vol. 12, pp. 667–679.
Uehara, T., Jin, Z.L., Ogawa, K., et al., Nucl. Med. Biol., 2007, vol. 34, pp. 79–87.
De Rosales, R.T.M., Finucane, C., Foster, J., et al., Bioconjug. Chem., 2010, vol. 21, pp. 811–815.
Ogawa, K. and Mukai, T., J. Drug Deliv. Sci. Technol., 2009, vol. 19, pp. 171–176.
Ogawa, K., Takai, K., Kanbara, H., et al., Nucl. Med. Biol., 2011, vol. 38, pp. 631–636.
Ogawa, K., Kawashima, H., Shiba, K., et al., Nucl. Med. Biol., 2009, vol. 36, pp. 129–135.
Ogawa, K. and Washiyama, K., Curr. Med. Chem., 2012, vol. 19, pp. 3290–3300.
Oldberg, A., Franzen, A., and Heinegard, D., Proc. Natl. Acad. Sci. USA, 1986, vol. 83, pp. 8819–8823.
Oldberg, A., Franzen, A., and Heinegard, D., J. Biol. Chem., 1988, vol. 263, pp. 19430–19 432.
Wang, D., Miller, S., Sima, M., et al., Bioconjug. Chem., 2003, vol. 14, pp. 853–859.
Sanad, M.H. and Ibrahim, A.A., Radiochim. Acta, 2018, vol. 106, no. 3, pp. 229–238.
Vitha, T., Kubicek, V., Hermann, P., et al., J. Med. Chem., 2008, vol. 51, pp. 677–683.
Kaiser, E., Colescott, R.L., Bossinger, C.D., and Cook, P.I., Anal. Biochem., 1970, vol. 34, pp. 595–598.
Fellner, M., Baum, R.P., Kubicek, V., et al., Eur. J. Nucl. Med. Mol. Imag., 2010, vol. 37, p. 834.
Even-Sapir, E., Metser, U., Mishani, E., et al., J. Nucl. Med., 2006, vol. 47, pp. 287–297.
Zhernosekov, K.P., Filosofov, D.V., Baum, R.P., et al., J. Nucl. Med., 2007, vol. 48, pp. 1741–1748.
Suzuki, K., Satake, M., Suwada, J., et al., Nucl. Med. Biol., 2011, vol. 38, pp. 1011–1018.
Notni, J., Plutnar, J., and Wester, H.J., EJNMMI Res., 2012, vol. 2, p. 13.
Kubicek, V., Rudovsky, J., Kotek, J., et al., J. Am. Chem. Soc., 2005, vol. 127, pp. 16 477–16 485.
Muhammad, U.A., Tanveer, H.B., Samina, R., et al., Russ. J. Bioorg. Chem., 2016, vol. 42, no. 5, pp. 491–496.
Author information
Authors and Affiliations
Corresponding author
Additional information
The text was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
Motaleb, M.A., Sanad, M.H., Selim, A.A. et al. Synthesis, Characterization, and Radiolabeling of Heterocyclic Bisphosphonate Derivative as a Potential Agent for Bone Imaging. Radiochemistry 60, 201–207 (2018). https://doi.org/10.1134/S106636221802011X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S106636221802011X